A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation

Hepatitis B virus (HBV) reactivation reportedly occurs frequently after hematopoietic stem cell transplantation (HSCT) in resolved HBV-infected patients. Here, 50 patients with resolved HBV infections and scheduled to undergo HSCT were enrolled; all subjects were vaccinated with three doses of hepat...

Full description

Saved in:
Bibliographic Details
Published in:Bone Marrow Transplant
Main Authors: Nishikawa, Koji, Kimura, Kiminori, Kanda, Yoshinobu, Sugiyama, Masaya, Kakihana, Kazuhiko, Doki, Noriko, Ohashi, Kazuteru, Bae, Sung Kwan, Takahashi, Kazuhiro, Ishihara, Yuko, Mizuno, Ishikazu, Onishi, Yasushi, Onozawa, Masahiro, Onizuka, Makoto, Yamamoto, Masahide, Ishikawa, Tetsuya, Inoue, Kazuaki, Kusumoto, Shigeru, Hashino, Satoshi, Saito, Hidetsugu, Kanto, Tatsuya, Sakamaki, Hisashi, Mizokami, Masashi
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329632/
https://ncbi.nlm.nih.gov/pubmed/32071416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-0833-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items